Bernaola, 1,645 patient HCQ late treatment study: 17% lower mortality [p<0.0001] https://c19p.org/bernaola
copied to clipboard
Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid
et al., medRxiv, doi:10.1101/2020.07.17.20155960 (Preprint)
HCQ HR 0.83 [0.77-0.89] based on propensity score matched retrospective analysis of 1,645 hospitalized patients. Prednisone HR 0.85 [0.82-0.88], 14 other medications showed either no signicant benefit or a negative effect.
|
risk of death, 17.0% lower, HR 0.83, p < 0.001, treatment 236 of 1,498 (15.8%), control 28 of 147 (19.0%), NNT 30.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Bernaola et al., 7/21/2020, retrospective, Spain, Europe, preprint, 7 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.